title: Severe methylenetetrahydrofolate reductase deficiency in mice results in behavioral anomalies with morphological and biochemical changes in hippocampus.
abstract: The brain is particularly sensitive to folate metabolic disturbances, since methyl groups are critical for its functions. Methylenetetrahydrofolate reductase (MTHFR) generates the primary circulatory form of folate required for homocysteine remethylation to methionine. Neurological disturbances have been described in homocystinuria caused by severe MTHFR deficiency. The goal of this study was to determine if behavioral anomalies are present in severe Mthfr-deficient (Mthfr(-/-)) mice and to identify neurobiological changes that could contribute to these anomalies. Adult male mice of 3 Mthfr genotypes (+/+, +/-, -/-) were tested on motor, anxiety, exploratory and cognitive tasks. Volumes (whole brain and hippocampus) and morphology, global DNA methylation, apoptosis, expression of choline acetyltransferase (ChAT) and glucocorticoid receptor (GR), and concentrations of choline metabolites were assessed in hippocampus. Mthfr(-/-) mice had impairments in motor function and in short- and long-term memory, increased exploratory behavior and decreased anxiety. They showed decreased whole brain and hippocampal volumes, reduced thickness of the pyramidal cell layer of CA1 and CA3, and increased apoptosis in hippocampus. There was a disturbance in choline metabolism as manifested by differences in acetylcholine, betaine or glycerophosphocholine concentrations, and by increased ChAT levels. Mthfr(-/-) mice also had increased GR mRNA and protein. Our study has revealed significant anomalies in affective behavior and impairments in memory of Mthfr(-/-) mice. We identified structural changes, increased apoptosis, altered choline metabolism and GR dysregulation in hippocampus. These findings, as well as some similar observations in cerebellum, could contribute to the behavioral changes and suggest that choline is a critical metabolite in homocystinuria.
authors.affiliation: Department of Human Genetics, McGill University, Montreal Children's Hospital Research Institute, 4060 Ste. Catherine West, Montreal, Canada H3Z 2Z3. nafisa.jadavji@mail.mcgill.ca
authors.forename: Nafisa M
authors.initials: NM
authors.lastname: Jadavji
authors.forename: Liyuan
authors.initials: L
authors.lastname: Deng
authors.forename: Daniel
authors.initials: D
authors.lastname: Leclerc
authors.forename: Olga
authors.initials: O
authors.lastname: Malysheva
authors.forename: Barry J
authors.initials: BJ
authors.lastname: Bedell
authors.forename: Marie A
authors.initials: MA
authors.lastname: Caudill
authors.forename: Rima
authors.initials: R
authors.lastname: Rozen
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001522:Behavior, Animal; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002531:Cerebellum / Q000378:metabolism / Q000473:pathology; D002794:Choline / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D019175:DNA Methylation; D006624:Hippocampus / Q000378:metabolism* / Q000473:pathology*; D006710:Homocysteine / Q000097:blood; D006712:Homocystinuria / Q000175:diagnosis* / Q000235:genetics; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000172:deficiency / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009128:Muscle Spasticity / Q000175:diagnosis* / Q000235:genetics; D009929:Organ Size; D011618:Psychotic Disorders / Q000175:diagnosis / Q000235:genetics; D011965:Receptors, Glucocorticoid / Q000378:metabolism
chemical_list: D011965:Receptors, Glucocorticoid; D006710:Homocysteine; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D002795:Choline O-Acetyltransferase; D002794:Choline